Silvant Capital Management LLC Dexcom Inc Transaction History

Silvant Capital Management LLC

$2.35 Billion
Q4 2024

A detailed history of Silvant Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Silvant Capital Management LLC holds 33,428 shares of DXCM stock, worth $2.36 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

33,428

Previous 243,587 86.28%

Holding current value

$2.36 Million

Previous $16.3 Million 84.08%

% of portfolio

0.11%

Previous 0.73%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$65.68 - $81.01 $13.8 Million - $17 Million	-210,159 Reduced 86.28%	33,428 $2.6 Million
Q3 2024 Oct 29, 2024	SELL	$64.0 - $116.06 $2.35 Million - $4.26 Million	-36,702 Reduced 13.09%	243,587 $16.3 Million
Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $2.01 Million - $2.55 Million	18,189 Added 6.94%	280,289 $31.8 Million
Q1 2024 Apr 30, 2024	BUY	$114.22 - $140.1 $123,586 - $151,588	1,082 Added 0.41%	262,100 $36.4 Million
Q4 2023 Jan 25, 2024	BUY	$75.49 - $124.16 $331,929 - $545,931	4,397 Added 1.71%	261,018 $32.4 Million
Q3 2023 Oct 24, 2023	SELL	$86.06 - $137.93 $106,972 - $171,446	-1,243 Reduced 0.48%	256,621 $23.9 Million
Q2 2023 Jul 25, 2023	BUY	$112.47 - $130.98 $547,054 - $637,086	4,864 Added 1.92%	257,864 $33.1 Million
Q1 2023 Apr 26, 2023	SELL	$104.0 - $122.92 $320,528 - $378,839	-3,082 Reduced 1.2%	253,000 $29.4 Million
Q4 2022 Jan 23, 2023	SELL	$84.98 - $122.67 $2.38 Million - $3.43 Million	-27,954 Reduced 9.84%	256,082 $0
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $18.6 Million - $23 Million	244,240 Added 613.73%	284,036 $22.9 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $2.03 Million - $3.96 Million	29,815 Added 298.72%	39,796 $2.97 Million
Q1 2022 May 05, 2022	SELL	$94.08 - $130.2 $19,662 - $27,211	-209 Reduced 2.05%	9,981 $5.11 Million
Q4 2021 Feb 07, 2022	SELL	$129.87 - $162.82 $196,882 - $246,835	-1,516 Reduced 12.95%	10,190 $5.47 Million
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $165,507 - $222,072	-1,551 Reduced 11.7%	11,706 $6.4 Million
Q2 2021 Aug 03, 2021	SELL	$80.99 - $107.93 $10,771 - $14,354	-133 Reduced 0.99%	13,257 $5.66 Million
Q1 2021 May 11, 2021	SELL	$84.79 - $104.74 $19,671 - $24,299	-232 Reduced 1.7%	13,390 $4.81 Million
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $11,700 - $15,675	-150 Reduced 1.09%	13,622 $5.04 Million
Q3 2020 Nov 09, 2020	SELL	$95.51 - $112.95 $225,403 - $266,562	-2,360 Reduced 14.63%	13,772 $5.68 Million
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $93,017 - $156,324	1,484 Added 10.13%	16,132 $6.54 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $8,172 - $12,932	-171 Reduced 1.15%	14,648 $3.95 Million
Q4 2019 Feb 10, 2020	BUY	$36.62 - $57.29 $345,509 - $540,531	9,435 Added 175.24%	14,819 $3.24 Million
Q1 2019 May 10, 2019	BUY	$28.07 - $38.18 $151,128 - $205,561	5,384 New	5,384 $641,000

Others Institutions Holding DXCM

# of Institutions

1,083

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Account

Silvant Capital Management LLC Dexcom Inc Transaction History